BASF targets agrochemical sector
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BASF, Europe's biggest chemicals group, has emerged as a potential buyer of AstraZeneca's agrochemical business. BASF said it was willing to take part in any shake-up of the global agrochemical business, as the company unveiled a steep drop in second-quarter operating profits to 421m euros (pounds 280m) after 723m euros in the same period last year. Sales in the three months fell to 7.23bn euros from 7.31bn euros in the second quarter of 1998.
Management board chairman Jurgen Strube said in London yesterday that BASF was interested in raising its presence in agrochemicals. On Tuesday, Anglo-Swedish AstraZeneca said it wanted to shake up its agrochemicals business in the light of falling sales and profits. Observers believe it could exit the business completely.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments